- Longitudinal MRI-based fusion novel model to predict pathological complete response in breast cancer treated with neoadjuvant chemotherapy: A multicenter, retrospective studyWang, Kun; Huang, YuhongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Deep learning magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage invasive breast cancerHe, Z.; Yu, Y.; Ren, W.; Mao, L.; Tan, Y.; Wang, J.; Hu, Q.; Ouyang, Y.; Xie, C.; Yao, H.Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2021-09-16 To 2021-09-21.
- Magnetic resonance imaging radiomics predicts high and low recurrence risk and is associated with LncRNAs in early-stage invasive breast cancerRen, W.; Yu, Y.; He, Z.; Mao, L.; Chen, Y.; Ouyang, W.; Tan, Y.; Li, C.; Chen, K.; Ouyang, J.; Hu, Q.; Xie, C.; Yao, H.Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2021-09-16 To 2021-09-21.
会议论文
Longitudinal MRI-based radiomic model to complement sentinel lymph node biopsy assessment after neoadjuvant chemotherapy in initially clinically node-positive breast cancer: A multicentre, diagnostic study
9阅读
